Regina South
Medical · Carleton, MINPI 1497704142
Payments from drug & device makers
Across 104 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$420
- Vanda Pharmaceuticals Inc.$290
- AbbVie$213
- Neurocrine Biosciences, Inc.$127
- Otsuka America Pharmaceutical, Inc.$117
- USWM, LLC$96
- plus $707 from 18 others
What the payments were for
- Food & beverage$1,969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,969 in reported general payments places this provider in the 75th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $65,707 |
| MounjaroTirzepatide | 25 | $30,646 |
| TrulicityDulaglutide | 18 | $19,862 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $15,219 |
| Levemir FlexpenInsulin Detemir | 13 | $5,857 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 183 | $5,251 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $3,283 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,739 |
| Gabapentin | 147 | $2,399 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 74 | $2,136 |
| Duloxetine Hcl | 47 | $2,043 |
| Omeprazole | 144 | $1,879 |
| Atorvastatin Calcium | 180 | $1,401 |
| Colchicine | 13 | $1,179 |
| Potassium Chloride | 46 | $1,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $17 | $65,70752 claims |
| Lilly USA, LLCMounjaro, Trulicity | $43 | $50,50843 claims |
| GSKTrelegy Ellipta | $16 | $15,21919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 755 medical providers in Michigan.
Other medical in Carleton
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.